Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc clinical trials

Explore recruiting anaplastic lymphoma kinase alk positive non small cell lung cancer nsclc clinical trials.

Recruiting anaplastic lymphoma kinase alk positive non small cell lung cancer nsclc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

eXALT3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Poland, France, Spain, Czechia, Belgium, Netherlands +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Crizotinib In Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer

Poland, Spain, Portugal, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients with Completely Resected Stage Ib (Tumors ≥ 4 Cm) to Stage IIIa Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer

Romania, Denmark, Spain, Austria, Hungary, France +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc trials by city

Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Toronto Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Vancouver Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Montreal Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Calgary Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Edmonton Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Ottawa Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Winnipeg Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Quebec City Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Hamilton Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Kitchener Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in London Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Halifax Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in New York Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Los Angeles Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Chicago Anaplastic Lymphoma Kinase Alk Positive Non Small Cell Lung Cancer Nsclc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease